August 6, 2024
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
DUBLIN, Ireland (August 06, 2024) – Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, obtained an extension to demonstrate compliance with a continued listing requirement of The Nasdaq Global Select Market.